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Introduction: Pregnancies in the world each year involve women
who have or who will develop psychiatric illness during the preg-
nancy. Psychotropics in gestation could produce adverse perinatal and
postnatal outcomes, however counseling these women to discontinue
medication presents new risks associated with untreated or inade-
quately treated mental illness, such as poor prenatal care, inadequate
nutrition, and increased alcohol and tobacco use. The single adminis-
tration at a higher dosage over multiple medications, active pharma-
ceutical compounds with fewer metabolites and higher protein bind-
ing are preferred. Nevertheless all psychotropic medications cross the
placenta, are present in amniotic ﬂuid, and can enter breast milk.
Case description: The FDA, the Australian Drug Evaluation Committee
and Micromedex have categorized medications according to risk during
pregnancy. Based on these classiﬁcations Benzodiazepines, have been
demonstrated possibly teratogenic however they are still used for treating
anxiety, panic, seizures and insomnia. International Pharmacopoeia
reported an increased risk of intrauterine growth retardation, hypotonia,
bradycardia, respiratory depression, low Apgar and preterm delivery for
fetal plasma drug concentrations equivalent to the therapeutic range of
maternal prescription. Very few data are published on sudden intrauter-
ine death (SIUD) for intrauterine exposure to psychotropic medication.
We describe a SIUD correlated with unexpected toxic plasmatic fetal
concentration of Lorazepam.
Results and conclusions: The pregnant manifested anxiety, panic
attack and deﬁciency of emotional transport for the fetus. She was treated
with Lorazepam evening dose of 2mg from 24 to 40 gestational weeks,
according to therapeutic range prescription, when suddenly and unex-
pectedly fetus died in utero just before the delivery. We evaluated the
maternal and fetal pharmacological plasmatic concentration and observed
a fetal plasmatic level of Lorazepam of 330mcg/l greater the toxic cutoff of
45mcg/l, suggested by Micromedex to cause "ﬂoppy infant" syndrome. By
autoptic diagnosis we hypothesized neuropathological signs of sudden
cardiac arrest in health fetus.
Take-home message: We propose that the monitoring of the
maternal plasma levels of benzodiazepines during pregnancy and
assessment of the concentration umbilical cord at birth, have to be
correlated with the fetal vital signs. Nevertheless, it is difﬁcult to deﬁne
the metabolic fate of drugs in utero. Each of the major metabolic
pathways can be promoted by placental and/or fetal enzymes and the
metabolite concentration in the fetus does not ineludibly reﬂect the
ability of the fetus to metabolize drugs. For this reason it has to be
strictly evaluated the toxicological etiopathogenesis of some cases of
SIUD and still birth.
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Introduction: Marcus Gunn Syndrome, also known as Jaw Wink Syn-
drome or trigemino-oculomotor synkinesis, was ﬁrst reported in 1883. It
typically presents at birth with unilateral ptosis and eyelid elevation on
jaw opening. Pathophysiology is explained by an oculofacial synkinesis.
There is an aberrant connection of the oculomotor nerve and the man-
dibular branch of the trigeminal nerve resulting in eyelid elevation on
mouth opening. The typically congenital syndrome is exceptionally rare. It
is often diagnosed in infancy with complete ophthalmic examination and
ptosis evaluation. This syndrome does not often require surgical inter-
vention but it may still have an impact in clinical management.
Case description: A 32-year-old male presented in the OMFS out-
patient clinic in Countess of Chester Hospital for extraction of his lower
third molars. His past medical history included a known diagnosis of
Marcus Gunn Syndrome but he was otherwise ﬁt and well. He had resting
ptosis of the left and elevation of the left eyelid on jaw protrusion.
Results and conclusions: Third molars were removed uneventfully
under local anesthesia and no further treatment was required. Literature
suggests that patients with Marcus Gunn Syndrome may have an atypical
oculocardiac reﬂex during their surgical procedure and patients are at
increased risk of malignant hypothermia. In this case, the procedure was
performed under local anesthesia but this condition may impact on sur-
gical planning if general anesthesia was to be considered.
http://dx.doi.org/10.1016/j.nhccr.2017.06.143
Rash or infection? An uncommon case of fever with
skin lesions
Gaël Villanueva-Charbonneaun
Centre hospitalier afﬁlié universitaire régional de Trois-Rivières,
Trois-Rivières, Québec, Canada
Introduction: Acute generalised exanthematous pustulosis (AGEP) is rare
form of late hypersensitivity syndrome that can be sometimes mistaken as a
skin infection. The differential diagnosis of infectious pustular lesion is large
but it can also appear in the setting of a complete non-infectious estate.
Case description: We present a 40-year-old woman from a French-
Canadian background who developed pustular lesions all over her body in
the setting of fever, weakness and headache. She was previously affected
by an Henoch–Schönlein purpura and developed secondary chronic
infectious leg skin lesions.
Result and conclusion: Two months before the apparition of the
pustules, she was treated by many different antibiotics (cephalexin,
